Improving Diabetes Medication Adherence for African Americans in Madison and Milwaukee Through Peer Support
Completed · Not applicable
Conditions studied: Type2 Diabetes, Medication Adherence, Medication Nonadherence, Peer Support
In brief
The burden of diabetes is higher among African Americans (AAs) in Wisconsin as hospitalization rates for diabetes complications such as stroke and amputations are four times higher than whites and has worsened by 334% since 2011. The most important self-management behavior for improving diabetes outcomes is medication adherence, i.e., taking medicines as recommended by providers. Poor adherence to diabetes medications is common among AAs and contributes to disproportionally worse outcomes. While the reasons for nonadherence are multifactorial, health beliefs, lack of self-efficacy, social support, and limited health literacy, are critical factors for AAs. Due to discrimination experiences and provider distrust, AAs may have health beliefs that do not align with biomedicine. Existing adherence interventions designed for general populations may be ineffective for AAs because they do not adequately address these fundamental factors. The intervention is peer-led, such that AAs who have diabetes and are adherent to their medicines (Peer Ambassadors- (PAs)) are paired with AAs who have diabetes and are nonadherent (Peer Buddies- PBs)).Throughout the 8-week program, PAs actively support and teach PBs about self-advocacy in patient-provider relationships, as well as sharing their experiences managing diabetes, providing social support, enhancing health literacy, patient activation (engagement and empowerment) and self-efficacy. PAs help deliver the intervention via initial face-to-face and phone/app follow-ups with PBs, in addition to structured group education delivered to PBs by a physician, pharmacist, and diabetes educator separately. The investigator's aim is to use a community-engaged design to pilot the intervention, assessing the feasibility of gathering pre/post outcomes including culturally-informed diabetes-health beliefs, self-efficacy, patient activation, medication adherence (using surveys), and A1c, and further refine the intervention via feedback from an advisory board comprised of the PAs. The investigators hypothesize that the intervention will be feasible for AAs with diabetes. This study uses a collaborative approach involving patient stakeholders throughout the research process by directly engaging AAs with diabetes to utilize their experience, knowledge and advice. This project advances the development of culturally-appropriate medication adherence interventions for AAs with diabetes.
Key facts
- Study ID
- NCT04028076
- Run by
- University of Wisconsin, Madison
- People needed
- 20
- Starts
- 2019-07-10
- Expected to finish
- 2020-10-05
- Last updated by the study team
- 2020-10-12
Who can join
Age: 30 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Peer Ambassadors:
- Men and women 30-65 years old with type 2 diabetes who self-identify as Black/AA and can speak/read English at a 6th grade level,
- Self-report as prescribed one oral diabetes medication and are adherent to taking it (11 on the ARMS-D scale),
- Have access to/can use a phone with cellular/internet use during the study.
- Peer Buddies:
- Men and women 30-65 years old with type 2 diabetes who self-identify as Black/AA and can speak/read English at a 6th grade level,
- Self-report as prescribed one oral diabetes medication and are non-adherent to taking it (greater than 11 on the ARMS-D scale)
- Have access to/can use a phone with cellular/internet use during the study.
You may not qualify if…
- Peer Ambassadors:
- Individuals who are only using insulin (adherence may differ for these individuals)
- Individuals who report diagnosis of mental illness/psychosis.
- Peer Buddies:
- Individuals who are only using insulin (adherence may differ for these individuals),
- Individuals who have a diagnosed psychiatric disorder
Where it is running
- University of Wisconsin - Madison — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.